-+ 0.00%
-+ 0.00%
-+ 0.00%

PASITHEA THERAPEUTICS ANNOUNCES POSITIVE PAS-004 CLINICAL DATA FROM PHASE 1 ADVANCED CANCER STUDY PRESENTED AT ESMO CONGRESS 2026

Reuters·10/23/2026 13:17:23